Impact of sex and menopausal hormonal therapy on cardiovascular diseases in people with diabetes or prediabetes
Abstract People with diabetes or prediabetes face a higher risk of cardiovascular events. However, the impact of sex and menopausal hormone therapy on cardiovascular disease (CVD) in these individuals remains unclear. We examined cardiovascular event risk and the association between menopausal hormo...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-01768-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849763406948597760 |
|---|---|
| author | Do Kyeong Song Yeon-Ah Sung Young Sun Hong Min-ho Kim Hyejin Lee |
| author_facet | Do Kyeong Song Yeon-Ah Sung Young Sun Hong Min-ho Kim Hyejin Lee |
| author_sort | Do Kyeong Song |
| collection | DOAJ |
| description | Abstract People with diabetes or prediabetes face a higher risk of cardiovascular events. However, the impact of sex and menopausal hormone therapy on cardiovascular disease (CVD) in these individuals remains unclear. We examined cardiovascular event risk and the association between menopausal hormone therapy and CVD risk in female Koreans with diabetes or prediabetes. We utilized the National Health Insurance Service database from 2009 to 2019. People undergoing hemodialysis or with an eGFR < 15 mL/min/1.73 m2 were excluded. We analyzed 1,313,591 people with prediabetes and 890,184 people with diabetes without a history of heart failure. Additionally, we examined 1,180,576 people with prediabetes and 673,688 people with diabetes without a history of acute myocardial infarction or stroke. Hazard ratios (HRs) for CVD risk were calculated using Cox proportional hazards models. Women with diabetes had a higher risk of heart failure compared to men with diabetes (HR: 1.095, 95% CI 1.068 to 1.123), a pattern also seen in people with prediabetes (HR: 1.150, 95% CI 1.118 to 1.183). Conversely, women with diabetes had a lower risk of acute myocardial infarction (HR: 0.507, 95% CI 0.486 to 0.528) and stroke (HR: 0.787, 95% CI 0.771 to 0.804) compared to men with diabetes, which was similarly observed in people with prediabetes. Hormone therapy was linked to a reduced risk of ischemic stroke in postmenopausal women with diabetes (HR: 0.761, 95% CI 0.589 to 0.983) and prediabetes (HR: 0.659, 95% CI 0.488 to 0.889). Women with diabetes or prediabetes have a higher risk of heart failure than men. More intensive screening and management of heart failure are needed, especially for these women. Conversely, women with diabetes or prediabetes have a lower risk of acute myocardial infarction and stroke compared to men. Menopausal hormone therapy may help prevent ischemic stroke in postmenopausal women with diabetes or prediabetes. |
| format | Article |
| id | doaj-art-5eb5bb5284a945298c5d6b4dcfe7bcfd |
| institution | DOAJ |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-5eb5bb5284a945298c5d6b4dcfe7bcfd2025-08-20T03:05:25ZengNature PortfolioScientific Reports2045-23222025-07-011511910.1038/s41598-025-01768-8Impact of sex and menopausal hormonal therapy on cardiovascular diseases in people with diabetes or prediabetesDo Kyeong Song0Yeon-Ah Sung1Young Sun Hong2Min-ho Kim3Hyejin Lee4Department of Internal Medicine, Ewha Womans University School of MedicineDepartment of Internal Medicine, Ewha Womans University School of MedicineDepartment of Internal Medicine, Ewha Womans University School of MedicineEwha Womans University Seoul Hospital, Ewha Medical Data OrganizationDepartment of Internal Medicine, Ewha Womans University School of MedicineAbstract People with diabetes or prediabetes face a higher risk of cardiovascular events. However, the impact of sex and menopausal hormone therapy on cardiovascular disease (CVD) in these individuals remains unclear. We examined cardiovascular event risk and the association between menopausal hormone therapy and CVD risk in female Koreans with diabetes or prediabetes. We utilized the National Health Insurance Service database from 2009 to 2019. People undergoing hemodialysis or with an eGFR < 15 mL/min/1.73 m2 were excluded. We analyzed 1,313,591 people with prediabetes and 890,184 people with diabetes without a history of heart failure. Additionally, we examined 1,180,576 people with prediabetes and 673,688 people with diabetes without a history of acute myocardial infarction or stroke. Hazard ratios (HRs) for CVD risk were calculated using Cox proportional hazards models. Women with diabetes had a higher risk of heart failure compared to men with diabetes (HR: 1.095, 95% CI 1.068 to 1.123), a pattern also seen in people with prediabetes (HR: 1.150, 95% CI 1.118 to 1.183). Conversely, women with diabetes had a lower risk of acute myocardial infarction (HR: 0.507, 95% CI 0.486 to 0.528) and stroke (HR: 0.787, 95% CI 0.771 to 0.804) compared to men with diabetes, which was similarly observed in people with prediabetes. Hormone therapy was linked to a reduced risk of ischemic stroke in postmenopausal women with diabetes (HR: 0.761, 95% CI 0.589 to 0.983) and prediabetes (HR: 0.659, 95% CI 0.488 to 0.889). Women with diabetes or prediabetes have a higher risk of heart failure than men. More intensive screening and management of heart failure are needed, especially for these women. Conversely, women with diabetes or prediabetes have a lower risk of acute myocardial infarction and stroke compared to men. Menopausal hormone therapy may help prevent ischemic stroke in postmenopausal women with diabetes or prediabetes.https://doi.org/10.1038/s41598-025-01768-8SexHormone replacement therapyCardiovascular diseasesDiabetesPrediabetic state |
| spellingShingle | Do Kyeong Song Yeon-Ah Sung Young Sun Hong Min-ho Kim Hyejin Lee Impact of sex and menopausal hormonal therapy on cardiovascular diseases in people with diabetes or prediabetes Scientific Reports Sex Hormone replacement therapy Cardiovascular diseases Diabetes Prediabetic state |
| title | Impact of sex and menopausal hormonal therapy on cardiovascular diseases in people with diabetes or prediabetes |
| title_full | Impact of sex and menopausal hormonal therapy on cardiovascular diseases in people with diabetes or prediabetes |
| title_fullStr | Impact of sex and menopausal hormonal therapy on cardiovascular diseases in people with diabetes or prediabetes |
| title_full_unstemmed | Impact of sex and menopausal hormonal therapy on cardiovascular diseases in people with diabetes or prediabetes |
| title_short | Impact of sex and menopausal hormonal therapy on cardiovascular diseases in people with diabetes or prediabetes |
| title_sort | impact of sex and menopausal hormonal therapy on cardiovascular diseases in people with diabetes or prediabetes |
| topic | Sex Hormone replacement therapy Cardiovascular diseases Diabetes Prediabetic state |
| url | https://doi.org/10.1038/s41598-025-01768-8 |
| work_keys_str_mv | AT dokyeongsong impactofsexandmenopausalhormonaltherapyoncardiovasculardiseasesinpeoplewithdiabetesorprediabetes AT yeonahsung impactofsexandmenopausalhormonaltherapyoncardiovasculardiseasesinpeoplewithdiabetesorprediabetes AT youngsunhong impactofsexandmenopausalhormonaltherapyoncardiovasculardiseasesinpeoplewithdiabetesorprediabetes AT minhokim impactofsexandmenopausalhormonaltherapyoncardiovasculardiseasesinpeoplewithdiabetesorprediabetes AT hyejinlee impactofsexandmenopausalhormonaltherapyoncardiovasculardiseasesinpeoplewithdiabetesorprediabetes |